Canoo Inc.: Nasdaq/NYSE listing notice — Canoo gets Nasdaq Capital Market transfer approval; still fails $1 bid price rule

Canoo Inc.

Transfer from Nasdaq Global Select to Nasdaq Capital Market effective September 18, 2023 under same tickers GOEV and GOEVW.
Company remains non-compliant with $1.00 minimum bid price requirement; initial cure deadline is September 25, 2023.
If conditions met, Nasdaq may grant an additional 180-day compliance period on the Capital Market.
Options to regain compliance include a possible reverse stock split; no assurance of success.
Failure to cure within allotted period could result in delisting and a potential appeal to a Nasdaq hearings panel.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.82

Canoo Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5450(a)(1), 5810(c)(3)(A)

Exact text from the filing

ively. The Nasdaq Capital Market is a continuous trading market that operates in substantially the same manner as The Nasdaq Global Select Market and listed companies must meet certain financial requirements and comply with Nasdaq’s corporate governance requirements. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), if a company listed on The Nasdaq Capital Market is not deemed in compliance before the expiration of the 180-day compliance period, it will be afforded an additional 180-day compliance period, provided that on the 180th day of the first compliance period it meets the applicable marke

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-23-101194

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.